Vital Signs - Pay for Performance: Where is it Headed?

Vital Signs - Pay for Performance: Where is it Headed?

 

RELEASE DATE
23-May-2011
REGION
North America
Research Code: 9561-00-C6-00-00
SKU: HC00625-NA-MR_04098
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00625-NA-MR_04098

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on May 24, 2011, provides a strategic insight on the future of pay for performance scenario in healthcare.

Additionally, a company spotlight is provided for Valor Medical. Valor Medical has developed a cyanoacrylate monomer to treat cerebral aneurysms. Neucrylate™ AN will polymerize from a liquid to a sponge like material when it comes in contact with blood. Reimbursement and regulatory news from the FDA is also provided for week of May 2, 2011.

Table of Contents

This week's issue

This issue of Vital Signs, released on May 24, 2011, provides a strategic insight on the future of pay for performance scenario in healthcare. Additionally, a company spotlight is provided for Valor Medical. Valor Medical has developed a cyanoacrylate monomer to treat cerebral aneurysms. Neucrylate AN will polymerize from a liquid to a sponge like material when it comes in contact with blood. Reimbursement and regulatory news from the FDA is also provided for week of May 2, 2011.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-C6-00-00
Is Prebook No